Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development
- PMID: 14530324
- DOI: 10.4049/jimmunol.171.8.4040
Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development
Abstract
In the nonobese diabetic (NOD) mouse, pathogenic and suppressor CD4(+) T cells can be distinguished by the constitutive expression of CD25. In this study, we demonstrate that the progression of autoimmune diabetes in NOD mice reflects modifications in both T cell subsets. CD4(+)CD25(+) suppressor T cells from 8-, but not 16-wk-old NOD mice delayed the onset of diabetes transferred by 16-wk-old CD25-depleted spleen cells. These results were paralleled by the inhibition of alloantigen-induced proliferation of CD4(+)CD25(-) cells, indicating an age-dependent decrease in suppressive activity. In addition, CD4(+)CD25(-) pathogenic T cells became progressively less sensitive to immunoregulation by CD4(+)CD25(+) T cells during diabetes development. CD4(+)CD25(-) T cells showed a higher proliferation and produced more IFN-gamma, but less IL-4 and IL-10, whereas CD4(+)CD25(+) T suppressor cells produced significantly lower levels of IL-10 in 16- compared with 8-wk-old NOD mice. Consistent with these findings, a higher frequency of Th1 cells was observed in the pancreas of 16-wk-old compared with 8-wk-old NOD mice. An increased percentage of CD4(+)CD25(-) T cells expressing CD54 was present in 16-wk-old and in diabetic NOD, but not in BALB/c mice. Costimulation via CD54 increased the proliferation of CD4(+)CD25(-) T cells from 16-, but not 8-wk-old NOD mice, and blocking CD54 prevented their proliferation, consistent with the role of CD54 in diabetes development. Thus, the pathogenesis of autoimmune diabetes in NOD mice is correlated with both an enhanced pathogenicity of CD4(+)CD25(-) T cells and a decreased suppressive activity of CD4(+)CD25(+) T cells.
Similar articles
-
Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.J Immunol. 2005 Jan 15;174(2):680-7. doi: 10.4049/jimmunol.174.2.680. J Immunol. 2005. PMID: 15634886
-
Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.J Immunol. 2003 Jul 15;171(2):733-44. doi: 10.4049/jimmunol.171.2.733. J Immunol. 2003. PMID: 12847240
-
Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.J Immunol. 2004 Oct 1;173(7):4407-16. doi: 10.4049/jimmunol.173.7.4407. J Immunol. 2004. PMID: 15383571
-
CD3 antibody treatment stimulates the functional capability of regulatory T cells.Novartis Found Symp. 2003;252:279-86; discussion 286-90. Novartis Found Symp. 2003. PMID: 14609225 Review.
-
Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2.Front Biosci. 2006 Jan 1;11:921-7. doi: 10.2741/1848. Front Biosci. 2006. PMID: 16146782 Review.
Cited by
-
Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β.J Immunol. 2012 Jan 15;188(2):559-68. doi: 10.4049/jimmunol.1100335. Epub 2011 Dec 14. J Immunol. 2012. PMID: 22174447 Free PMC article.
-
Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.J Clin Invest. 2005 Oct;115(10):2934-43. doi: 10.1172/JCI25485. Epub 2005 Sep 22. J Clin Invest. 2005. PMID: 16184198 Free PMC article.
-
How defects in central tolerance impinge on a deficiency in regulatory T cells.Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14735-40. doi: 10.1073/pnas.0507014102. Epub 2005 Oct 3. Proc Natl Acad Sci U S A. 2005. PMID: 16203996 Free PMC article.
-
Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18181-6. doi: 10.1073/pnas.0708899104. Epub 2007 Nov 8. Proc Natl Acad Sci U S A. 2007. PMID: 17991775 Free PMC article.
-
The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.J Clin Immunol. 2008 Nov;28(6):685-96. doi: 10.1007/s10875-008-9237-9. Epub 2008 Sep 9. J Clin Immunol. 2008. PMID: 18780166
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials